Clinical and immunological assessment of HIV infection.

cover only aspects of the clinical presentation of HIVinfection resulting from the associated immunodeficiency and its laboratory assessment. Accurate clinical staging is essential for epidemiological monitoring of the HIV epidemic, overall, in patient selection for clinical trials, and is of increasing importance in the assessment of individual patients for therapeutic intervention. Laboratory monitoring is gaining increasing importance in the initial staging of disease in individual patients, in the identification of immunological progression of those patients who remain asymptomatic, and in the recruitment to and assessment of clinical trials of new therapeutic agents against HIV infection.

[1]  C. Lee.  Natural history of HIV infection. , 1992, AIDS care.

[2]  A. Bird.  Monitoring of disease progression of HIV infection , 1992 .

[3]  F. Miedema,et al.  Lymphocyte functional analysis in HIV infection: mechanisms and clinical relevance , 1992 .

[4]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[5]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[6]  P Bacchetti,et al.  Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. , 1991, BMJ.

[7]  M. Desco,et al.  Immunological and serological markers predictive of progression to AIDS in a cohort of HIV‐infected drug users , 1990, AIDS.

[8]  W. Borkowsky,et al.  Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. , 1990, The New England journal of medicine.

[9]  S. Steinberg,et al.  Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. , 1990, Annals of internal medicine.

[10]  J. Lundgren,et al.  T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverters. , 1990, AIDS.

[11]  J M Taylor,et al.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, The New England journal of medicine.

[12]  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. , 1990, Disease markers.

[13]  N. Jewell,et al.  Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. , 1990, Archives of internal medicine.

[14]  D. Ho,et al.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.

[15]  A. Phillips,et al.  Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. , 1989, AIDS.

[16]  F. Ognibene,et al.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. , 1989, Annals of internal medicine.

[17]  M. Bye,et al.  Prognostic factors and life expectancy in children with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. , 1989, American journal of diseases of children.

[18]  Christine A. Lee,et al.  The natural history of HIV infection. , 1989, AIDS care.

[19]  P. Pinsky,et al.  A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. , 1988, JAMA.

[20]  D. Cooper,et al.  Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. , 1988, The Journal of infectious diseases.

[21]  R. Chaisson,et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.

[22]  J. Goedert,et al.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.

[23]  J. Goedert,et al.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. , 1987, JAMA.